Perspective
Aug. 20, 2014
Ruling clarifies mass tort jurisdictional issue
The California Court of Appeal delivered a groundbreaking decision in pharmaceutical mass tort litigation that "specific jurisdiction can apply to the claims of a non-resident against a non-resident." By Paul R. Kiesel
On July 30, the California Court of Appeal, in Bristol-Myers Squibb Co. v. Superior Court (Anderson), 2014 DJDAR 10059, delivered a groundbreaking decision in pharmaceutical mass tort litigation. The ruling, which was certified for publication, draws support from the U.S. Supreme Court's instruction in Keeton v. Hustler Magazine Inc., 465 U.S. 770 (1984), that "the doctrine of specific jurisdiction can apply to the claims ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In